US Market for Cardiac Ablation Catheters 2016 – MedCore

US Market for Cardiac Ablation Catheters 2016 – MedCore


  • Year: 2016
  • Scope: 2012-2022
  • Region: United States
  • Published Date: 12/01/2015
  • Pages: 43
  • Type: MedCore

Cardiac ablation involves the destruction of a small piece of heart tissue to disrupt electrical signal transmission. More than 20 distinct types of cardiac arrhythmias have been recognized and each is associated with a different electro-cardiograph (ECG) recording pattern. Each type of arrhythmia requires slightly different treatment and depending on the circumstances, pharmaceuticals, surgical ablation or catheter ablation may be required.

There are a number of possible methods to create an appropriately sized lesion in the heart without causing too much damage to surrounding tissues. Radiofrequency (RF) treatment is the most commonly used method, involving the transmission of radio wave energy to cauterize a small section of heart tissue. Cryoablation creates a lesion by cooling tissue near the catheter tip to a temperature low enough to kill the cells. In addition, cryoablation catheters can be used for performing site testing by temporarily blocking electrical conductivity through a specific area of tissue without permanently destroying the cells involved. Laser ablation involves the use of a laser wand to create a lesion in a manner similar to that of RF ablation. However, in laser ablation, no physical contact between the tissue and the wand would be required, reducing the risk of certain complications. Microwave cardiac ablation functions in the same manner as RF ablation, but its development was abandoned by Boston Scientific after early trials showed a low long-term success rate. High intensity focused ultrasound (HIFU) cardiac ablation involves the use of precisely focused ultrasound to permanently disrupt electrical transmission in selected cardiac tissue. Theoretically, this procedure can be performed thoracoscopically, making it less invasive than most surgical procedures. In addition, because the HIFU energy is beamed from outside the heart, there is a lower risk of damage to peripheral areas. This treatment modality was developed by ProRhythm Inc., but the company dissolved in 2008 and their intellectual property was acquired by Misonix Inc. and Philips Medical. St. Jude Medical has developed the Epicor Medical HIFU cardiac ablation system; however, it is not available for sale in the U.S. at the time of writing.

The "US Market for Electrophysiology and Ablation Devices - 2016 (Forecasted to 2022) - MedSuite" includes analysis on the following companies currently active in this market:
St. Jude Medical
Boston Scientific
Biosense Webster
Philips Healthcare
Zoll Medical
C.R. Bard
GE Healthcare
Cardiac Science
Hansen Medical
Philips Healthcare
Stereotaxis Inc.

*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Thank you!

Report Type Info

Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.

Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.

Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.

Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.



Sign Up

Already have an account? Sign in